retatrutide clinical trial results weight loss efficacy LinkInBio Lilly's retatrutide shows 28% weight

That places it squarely in the compounded category, where the FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness or quality before they are marketed

For many women, especially those with metabolic dysfunction, it increases fertility

10.3389/fnbeh.2021.650833 Front Behav Neurosci

UK SmPC data indicate that semaglutide and liraglutide do not clinically affect the absorption of combined oral contraceptives

9/ Upcoming weight-loss medications 10/ The bottom line When you think of weight-loss medication, you might automatically think of GLP-1s like Wegovy and Zepbound